Cigna Corporation (CGN.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:01AM CEST
| Previous close | 326.55 |
| Open | 326.55 |
| Bid | 331.15 x 20000 |
| Ask | 331.50 x 20000 |
| Day's range | 326.55 - 326.55 |
| 52-week range | 219.70 - 337.20 |
| Volume | |
| Avg. volume | 16 |
| Market cap | 95.108B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 20.32 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 5.23 (1.60%) |
| Ex-dividend date | 04 Jun 2024 |
| 1y target est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare
Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare are part of the Zacks top Analyst Blog.
- Reuters
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, the health insurer said on Thursday. Cigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers including Boehringer Ingelheim, Teva and Alvotech at its Accredo pharmacy.
- Yahoo Finance
Walgreens launches specialty pharmacy unit to compete in new PBM era
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.
© 2024 Yahoo. All rights reserved.